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THE EFFECT OF ANDROGENS AND ESTROGENS ON HUMAN
SEBACEOUS GLANDS*
JOHN S. STRAUSS, M.D., ALBERT M. KLIGMAN, M.D., PH.D. AND PETER E. POCHI, M.D.
This paper deals with the mechanism of action
of androgens and estrogens on the human sebace-
ous gland. Our experimental objectives were the
following: 1) to quantitate the effects of these
hormones on sebaceous gland function: 2) to
determine their mode of action, whether directly
on the target organ itself or through systemic
pathways; and 3) to analyze the "antagonism"
between androgens and estrogens on the seba-
ceous gland.
MATERIALS AND METHODS
Most of the observations have been made on the
glands of the face, because the fully developed
glands of this region are very large and sebum
secretion is high (1—5).' We have centered our
attention particularly on the large sebaceous
follicles which are almost peculiar to this region
(6). Before puberty, the sebaceous glands are tiny
and insignificant, sometimes consisting of un-
differentiated anlage with occasional nests of
lipid-laden cells. In contrast, the postpubertal
sebaceous follicles are unique in that the usual
size relationships are inverted, the glands having
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acquired an extraordinary size and the hair having
been reduced to a mere vestige. Furthermore, the
sebaceous follicles contribute most of the surface
lipid on the face. These are the follicles which
become involved in acne, a disease which we have
under continuing study and which has been a
major stimulus to our interest in sebaceous gland
physiology.
The sebaceous gland is a holocrine gland which
delivers its product, sebum, by the casting off of
lipid-filled cells. The output of sebum, with
certain qualifications, as will be noted, is directly
proportional to gland size (6—8). The productivity
of the gland can be measured either directly by
gravimetric assay of collected sebum or indirectly
by histologic assessment of gland size. The former
is far more precise.
Gravimetric essay. The procedure has been
described elsewhere (8). The sebum produced on
the forehead from an area usually 6.45 square
centimeters in size is collected for a three hour
period. The area is delineated with adhesive tape
to prevent exchange of sebum with the sur-
rounding skin. The sebum is trapped on thin
absorbent cigarette papers held in place by gauze
and a rubber bandage. Subsequently, the lipid is
extracted from the papers with ether and weighed.
This method of trapping the sebum as it is pro-
duced overcomes one of the maj or difficulties
which in the past has plagued quantitative studies
of sebum output, namely the extraordinary
tendency for sebum to flow away and be lost (6).
With the above technic, we have found that sebum
production is relatively constant for any one
subject on repeated testing. Nevertheless, indi-
vidual values do vary, sometimes considerably so.
Thus, it is the trend of multiple readings that is of
significance.
Histology. Deep punch biopsy specimens, four
to seven millimeters in diameter, have been taken
from symmetrical non-bearded areas of the check
before and after hormone administration. Serial
sectioning is required for a reliable estimate of
gland size, because the glands vary in size and
shape from follicle to follicle. This method is
useful only for comparatively gross differences.
QUANTITATIVE EFFEcTS OF ANDROGENS ON THE
SEBAEOU5 GLANDS
1) Systemic Administration of Androgens
There is substantial evidence from animal
experimentation that the sebaceous glands are
under androgenic control (9—16). Testosterone
increases the size of the glands of immature rats;
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the glands of the adult animal undergo atrophy
alter orchiectomy. While it is generally felt that
the human sebaceous gland is also androgen-
sensitive, the evidence is scanty. After admin-
istering testosterone to castrate and eunuchoid
males, Hamilton observed increased oiliness of
the skin (17). However, no quantitative measure-
ments were made. In six prepuberal boys Rony
and Zakon observed histologic enlargement of the
pubic sebaceous glands when 25 milligrams of
testosterone propionate were given three times
a week for two weeks (18). Furthermore, indirect
evidence that the glands are under androgenic
control is afforded by the emergence of acne in
association with androgen secreting tumors or
androgen therapy.
Experimental
A. Prepuberal subjects. Fourteen prepuberal
children, eight boys and six girls, seven to eleven
years of age, were given methyl testosterone2 orally
daily for periods of 7 to 12 weeks. Five boys and
three girls received 50 milligrams daily; three
girls received 75 milligrams daily; and three boys
received 100 milligrams daily. The glands were
studied in cheek biopsy specimens before and
after treatment. The final biopsy was usually done
at the end of treatment (seven to twelve weeks).
In one subject, a specimen was removed at three
weeks.
In every case, except for two boys who received
100 milligrams daily, there was substantial en-
largement of the glands (Figure 1), although the
degree of enlargement varied from subject to
subject. The enlargement was already evident in
the three week specimen. By histologic criteria,
the boys and girls seemed to respond similarly,
although this cannot be considered final in view of
the crudity of the method. The individual differ-
ences in responsiveness are probably genetically
determined. One year later biopsy specimens of
two boys, not yet embarked into puberty, showed
regression of the glands. In most of these children,
slight oiliness of the face was noted while the
androgen was administered and the follicular
openings appeared enlarged. In no case did acne-
form lesions appear.
Sebum output was gravimetrically determined
in fifteen prepuberal boys, seven to 13 years of
age, who received 100 milligrams of methyl testos-
terone daily. In ten, there was a definite increase,
strikingly so in five (Figure 2). In three, the
2 Methyl testosterone supplied by Hubert C.
Peltier, M.D., Harold L. Upjohn, M.D., and
Porter F. Crawford, M.D., The Upjohn Com-
pany, Kalamazoo, Michigan, and as Oreton Ma
by C. Kenneth Hawkins, M.D., Schering Cor-
poration, Bloomfield, New Jersey.
increase was slight. Two were unresponsive.*
Sebum output fell to the control level rapidly
when the methyl testosterone was discontinued.
Next, the speed of response was determined.
One hundred milligrams of methyl testosterone
orally daily caused histologic enlargement in two
prepuberal girls after seven and thirteen days
respectively. The gravimetric data also indicated
definitely increased sebaceous activity in two to
three weeks (Figure 2). Because of the danger of
epiphyseal closure, the drug was not continued
for more than two months, and thus it was not
possible to determine whether maximal glandular
stimulation had been reached. However, in many
of the subjects, the output even after this short
period was definitely in the adult range. We
tentatively feel that androgen stimulation can
rapidly transform the skin into the postpubertal
type, anatomically and functionally. Within limits(children less than five years of age were not
studied) this androgen-induced metamorphosis is
not dependent on age or whether the individual, is
about to enter puberty.
The minimally effective androgenic stimulus
may also be considered an index of gland sensi-
tivity. Two prepuberal boys received the small
dose of 5 milligrams of methyl testosterone orally
daily. Six weeks later, the glands had greatly
enlarged. In three of six prepuberal boys, 5 milli-
grams of methyl testosterone orally daily caused
a modest increase in sebaceous secretion. This
dose appears to be close to the threshold. As will
be pointed out, 5 milligrams of methyl testosterone
orally daily is less than the estimated adult
endogenous secretion of androgens, thus high-
lighting the great sensitivity of the gland to this
hormone. We did not quantitatively determine the
dose-response relationship, but did show that 100
milligrams of methyl testosterone orally daily
brought about a much greater increase in seba-
ceous secretion than 5 milligrams orally daily.
B. Post-puberal males. Six adult males, between
20 and 30 years of age, were given 100 milligrams
of methyl testosterone orally daily. Post-treat-
ment biopsy specimens at six weeks were com-
pared to controls. No changes were seen histo-
logically or clinically. Similarly, three adult males
received up to 300 milligrams of methyl testos-
terone daily for eight weeks. Sebum production
did not increase in any case.
C. Post-puberal females. Eight post-puberal
females in the second and third decade received
100 milligrams of methyl testosterone daily orally
for six weeks. Histologically, four showed slight
enlargement of the sebaceous glands. Two other
females received 200 milligrams of methyl testos-
* We cannot account for the complete androgen
insensitivity of occasional prepuberal subjects.Attention is called to the fact that the subjects in
these particular studies were mental defectives
with a variety of associated physical abnormalities
and stunted, retarded growth. Lack of absorption
may be one factor.
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FIG. 1. Enlargement of the prepuberal sebaceous glands of the cheek of an eleven year old boy given
100 milligrams of methyl testosterone orally daily for twelve weeks. A) Pretreatment specimen. Sehace-
ous glands are small lateral outpocketings of undifferentiated cells. B) Post-treatment specimen. The
glands and the follicles have greatly enlarged. Note that the corium has thickened too. This magnifi-
cation is the same as A (hematoxylin and eosin, X 39).
terone daily for six weeks. One developed glandu-
lar hyperplasia; the other did not respond. Un-
fortunately, the more sensitive gravimetric assay
method was not used.
D. Aged females. The sebaceous glands of the
female are thought to undergo involution partially
in old age, probably reflecting a diminished hor-
monal stimulation (19, 20). Three elderly females,
over 65 years of age, received 100 milligrams of
methyl testosterone daily orally for six to eight
weeks. In each ease, sebum production increased
slightly, but not as rapidly as in the prepuberal
subjects (Figure 3).
Comment
Exogenous androgen brings about prompt
enlargement and increased secretion of the
sebaceous glands of subj eets in the prepuberal
age group. The degree of enlargement with an
adequate stimulus varies from subject to subject
and probably depends more on the genetic
responsiveness of the target organ than on the
dose. The gland is highly androgen-sensitive.
As little as 5 milligrams of methyl testosterone
2.0
1,5
I.0
daily causes enlargement which becomes evident
in two to three weeks.
Male sex hormone is not a single compound
but a family of substances derived primarily from
the adrenal glands and the testes (21). Individual
androgens vary greatly in potency. Even the
determination of total androgen secretion poses
great technical problems. However, Fukushima,
et al., basing their estimates on studies with
radioactive testosterone, suggest that the daily
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FIG. 2. Sebum output of an eleven year old prepuberal male given two courses of methyl testosterone
orally (100 milligrams per day). Sebaceous secretion promptly rose with androgenic stimulation and
quickly declined to the original level when the drug was stopped.
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Fia. 3. Sebum production of three elderly post-menopausal females given 100 milligrams of methyl
testosterone orally daily. Sebaceous secretion slightly but consistently increased while the drug was
taken; it decreased when the androgen was stopped.
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endogenous production of androgen in the human
adult male, measured as testosterone, is about 17
milligrams per day and certainly no more than
36 milligrams per day (22). Since oral methyl
testosterone has one-third the potency of circu-
lating testosterone (23), our routine 100 milligram
dose falls in the upper portion of the normal
range, while the minimally effective dose of 5
milligrams is well below the average level. Pre-
sumably, the endogenous secretion of androgen
in the adult male is probably in excess of that
required to maintain maximal sebaceous gland
function.
The extraordinary androgen sensitivity of the
glands has been demonstrated in still another
way. 17-alpha-ethynyl-19-nor-testosterone (Nor-
lutin®) is a synthetic progestin with no significant
androgenic activity in animal assays utilizing
weight increases of the seminal vesicles and
ventral prostate gland of immature castrated
rats (24). Yet many female infants, born of
mothers receiving this compound during preg-
nancy, have varying degrees of pseudohermaph-
rodism (25, 26). We have found that 20 milligrams
of this compound causes enlargement of the
prepuberal sebaceous glands (27, 28). Accord-
ingly, we have suggested that the human pre-
puberal sebaceous gland provides a delicate
biological test system for detecting androgenicity
(28).
Though we have focused on the sebaceous
gland, androgens have far reaching effects on
prepuberal skin. The effect is one of general
stimulation; the corium thickens greatly, the
vasculature increases, the follicles lengthen, etc.
(Figure 1).
At first we thought it surprising that the glands
of adult males did not enlarge after strong
androgenic stimulation. One need only realize,
however, that in the post-adolescent male the
glands of any given subject are already respond-
ing to endogenous androgens which are ordinarily
in excess of that required for maximal effect.
The situation is somewhat different in the
post-puberal female. Despite some controversy,
females on the average secrete less sebum than
males (3, 29—31). We have confirmed this in our
own gravimetric studies (unpublished data).
Acne is less severe and less frequent in females
(32). Also, the endogenous secretion of androgen
by the female is about two-thirds that of the
males. The fact that exogenous testosterone
causes slight enlargement in some post-adolescent
females probably indicates that the endogenous
androgen output is somewhat less than that which
would enable the glands to achieve their full
responsiveness.
2) Local Application of Testosterone
The question with which we are concerned here
is whether testosterone exerts a direct action on
the target organ. Topical application, by pre-
sumably concentrating the drug locally in the
skin, permits one to decide whether this is the
case or not. One has to be aware, however, that
the changes produced by such a potent, readily
absorbed hormone might be part of a generalized
response following absorption of the drug through
the skin. To prove that testosterone acts directly
on the target organ, one must show that glandular
enlargement occurs earlier and to a greater
degree at the local site. Therefore, a series of
observations have to be made, all of which are
controlled by determining any changes of the
contralateral untreated side.
An alternate method would consist of super-
ficially injecting the testosterone in a repository
form. We abandoned this approach when we
found that injection of depot testosterone caused
dermal inflammation and partial involution of
the glands. Dermal inflammation has been found
to cause atrophy of the glands invariably (33).
Experimental
This study utilized prepuberal subjects ex-
clusively because of the high androgenic sensi-
tivity of their glands. The scalp is another area
where the glands reach great size in adults. There-
fore, after determining that the glands of the face
and scalp respond in a parallel and proportionate
fashion to androgen, we utilized the scalp in some
cases.
In four prepuberal boys, 9 to 11 years old, 10
per cent testosterone propionate in Hydrophylic
Ointment, DSP., was applied once daily to one
side of the scalp. A control biopsy specimen was
removed beforehand; biopsy specimens were ob-
tained from the treated and contralateral control
sites after the application had been continued for
three weeks. Although there was modest enlarge-
ment in the control areas indicating systemic
effects through absorption, the glands of the
Testosterone propionate supplied by G.
Kenneth Hawkins, M.D., Schering Corporation,
Bloomfield, New Jersey, and by Porter F. Craw-
ford, M.D., Hubert C. Peltier, M.D., and Harold
L. Upjohn, M.D., The Upjohn Company, Kala-
mazoo, Michigan.
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treated area underwent a strikiag increase in size
in each case (Figure 4).
In two other prepuberal males, 10 per cent
testosterone ointment was applied to one cheek
once daily for two months. There was great and
FIG. 4. Sebaceous gland enlargement produced
by daily inunction of approximately 0.1 gram of
10 per cent testosterone propionate ointment for
three weeks on the scalp of a prepuberal boy. A)
Control specimen with small glands. B) Glands
have enlarged at the site of application. C) Slight
or questionable enlargement of glands of un-
treated control site. Biopsy specimen taken at
same time as B. (Hematoxylin and eosin, A, B,
& C x 55).
equal glandular enlargement on both sides showing
that percutaneous absorption is sufficient to
achieve maximal effects throughout the skin when
inunctions of androgen in a high concentration are
carried out for many weeks.
Comment
The evidence is compelling that testosterone
has a direct local action on the sebaccous gland.
Enlargement occurs to a far greater degree at
the treated site (three-week experiment) and is
followed by a generalized uniform response due
to systemic absorption (two-month experiment).
The inunction consisted of approximately 0.1
to 0.2 grams of ointment daily, which would
therefore contain 10 to 20 milligrams of testos-
terone propionate. Even if only 10 per cent (1 to 2
milligrams) of testosterone propionate were
absorbed, androgenic effects could be expected
according to the data previously given. Perhaps
by progressively reducing the concentration of
hormone, one could find a threshold amount
which would limit the enlargement to the site of
application.
The present findings correlate well with other
studies which show a direct effect of androgcns on
the pilosebaceous apparatus of man (34—36).
When applied locally, testosterone causes in-
creased hair growth on the abdomen (34), in
the axilla (35, 36), and in the pubic area (36). To
extend these observations, 10 per cent testos-
terone propionate ointment was applied to one
axilla of four male prepuberal subjects, five,
seven, ten, and eleven years of age. In the two
oldest boys, the first hair growth occurred at the
site of application. After three months, terminal
hairs had developed both in the untreated axilla
and in the pubes, indicating systemic absorption.
The other two boys did not respond to the topical
androgen.
Enlargement of the cock's comb is commonly
used as a test of androgenicity (37). Morato-
Manaro and Albrieux applied an androgen to
one half of a comb which had been completely
divided surgically (38). Greater enlargement
occurred in the treated half of the comb, thus
further authenticating the direct action of testos-
terone.
QUANTITATIVE EFFECT OF ESTROGEN ON THE
SEBACEOU5 GLANn5
1) Systemic Administration of Estrogens
It is commonly accepted that estrogens have a
suppressive effect on human sebaceous secretion.
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The evidence usually cited is the reported thera-
peutic value of estrogens in acne vulgaris. Never-
theless, with the exception of the few eases
studied by Jarrett (39), one searches in vain for
objective, controlled clinical studies which
unequivocally demonstrate inhibition of sebace-
ous secretion. As a matter of fact, it will become
all too clear that the improvement of acne usually
claimed for estrogens, whether topical or oral, has
been achieved with amounts too small to inhibit
sebaceous output. Indeed acne is far too variable
and fluctuating a disease to be used casually as a
biological measurement of sebaceous gland
physiology. The time is overripe for direct
quantitative assessment, leaving aside the thorny
problem of acne.
In animals, on the other hand, the issue has
been settled beyond doubt. Ebling obtained
what he describes as "limited reduction" of the
sebaceous glands in rats weighing 40 to 60 grams
with the subcutaneous injection of 1.0 gamma of
estradiol benzoate daily for thirty days. However,
when 100 gamma of estradiol benzoate were given
under the same conditions, the decrease in the
sebaceous glands was marked (11). Others have
confirmed the depression of sebaceous glands in
animals with large amounts of estrogen (15,
40—43). On a comparative weight basis, even the
smallest dose that Ebling used, which would be
equivalent to a daily subcutaneous dose of 1.5
milligrams of estradiol benzoate for a 70 kilogram
human, is more than twice as large as the maxi-
mum therapeutic replacement dose for humans
(44, 45); Ebling's higher dosage is obviously
excessive.
Experimental
Of necessity all of the subjects were post-
puberal males and females with good glandular
development. The highly potent synthetic estro-
gen, ethynyl estradiol, was used in most of the
studies. In the experiments to be described, when
the dose was to exceed 1.0 milligram of ethynyl
estradiol, it was approached slowly over a period
of seven to ten days to avoid nausea and vomiting.
Fifteen milligrams of ethynyl estradiol orally
per day, the largest dose used, were given to three
adult males for six weeks. Histologically, the
glands became extremely atrophic and usually
were reduced to small nests of undifferentiated
cells. This shrinkage and involuting effect seemed
to be more or less restricted to the glands, ex-
empting the follicle and corium. Under the impact
of estrogen, the entire skin does not revert to its
prepuberal condition.
Four more males, between sixteen and twenty
years of age received 10 milligrams of ethynyl
estradiol daily for eight weeks with effects identi-
cal to that of the higher dose.
Thereafter, twenty young adult subjects (six-
teen males, four females) received 5 milligrams of
ethynyl estradiol daily for periods up to two
months. Again, the glands in every case became
almost completely atrophic, reverting to the prc-
puberal state in those with the greatest change
(Figure 5). There were individual differences in
the final degree of involution, but these could not
be correlated with original gland size. In all of the
subjects, the skin was subjectively and objectively
less oily.
Five milligrams of ethynyl estradiol greatly
suppressed sebaceous secretion in three subjects
(Figure 6). The decrease was detected in two to
three weeks, although the maximum effect oc-
curred later. This was a reversible change; sebum
output returned to normal eight to twelve weeks
after the drug was stopped. Similarly by histologic
examination of biopsy specimens from the cheek
of five adult males who received 5 milligrams of
ethynyl cstradiol daily, there was beginning
involution at three weeks and by four weeks the
decrease was unmistakable. Five weeks after the
drug was stopped, restoration was well under way
and by nine weeks the glands had regenerated
fully.
Seven young adult subjects (four males, three
females) received 2.5 milligrams of ethynyl cstra-
diol daily for six weeks. Here the histologic de-
crease in gland size was less. Moreover individual
responses were more variable. One female did not
respond at all.
Sebum output was gravimetrically estimated
in tbree males and two females who received 1.0
milligram of ethynyl estradiol daily. In each case,
sebum production was reduced significantly
(Figure 7). It should be emphasized that 1.0 milli-
gram is still many times the physiological re-
placement dose.
At this point, the greater sensitivity of gravi-
metric assay became apparent. By histologic
examination, doses of 1.0 and 0.5 milligrams failed
to cause atrophy of the glands in two groups of
five males each. By contrast, in six adult males
0.5 milligram of ethynyl estradiol definitely sup-
pressed sebaceous secretion (Figure 8). The lowest
dose evaluated was 0.25 milligram which gave a
questionable slight reduction in sebum production.
This is probably the threshold dose as measured
by sebum production. The disparity between
histologic and gravimetric suppression by estro-
gens is an exception to the well-founded principle
that sebaceous secretion is proportionate to gland
size. We tentatively hold that threshold doses of
estrogen may have the special effect of inhibiting
the proliferation of sebaceous cells without a
corresponding shrinkage of glandular size.
Three young adult males received 50 milligrams
Ethynyl cstradiol (Estinylit) supplied by G.
Kenneth Hawkins, M.D., Schering Corporation,
Bloomfield, New Jersey.
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Fin. 5. Depression of sebaceous glands of adult male by 5 milligrams of ethynyl estradiol orally daily
for six weeks. A) Pre-treatment specimen with lipid-laden, large sebaceous glands. B) After treatment,
the glands, which have been almost completely wiped out, are reduced to nubbins of undifferentiated
cells. (Hematoxylin and eosin, both A and B. X 32).
of diethylstilbestrol5 orally daily for six to eight milligrams, and two males received 40 milligrams
weeks. In each case there was moderate histologic of conjugated estrogenic substances (Premarin®)6
reduction in gland size, orally daily for six weeks. The 40 milligram dose
Finally, two young adult males received 20 caused a slight decrease in gland size while the
lower dose had little or no effect.Diethylstilbestrol supplied, by Hubert C. _______________________________________________
Peltier, M.D., Harold L. Upjohn, M.D., and 6 Conjugated estrogenic substances (Pre-Porter F. Crawford, M.D., The Upjohn Corn- marinR) supplied by Ayerst Laboratories, New
pany, Kalamazoo, Michigan. York, New York.
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Fm. 6. Suppressive effect of 5 milligrams of
ethynyl estradiol administered daily on the
sebaceous glands of an adult male. Sebum output
has declined greatly after three weeks, reaching a
maximum in four to six weeks. It takes 9 to 12
weeks for the secretory activity to recover fully
after stopping the drug. The changes in two other
adult males were similar.
Comment
It is quite evident that extremely high un-
physiologic amounts of estrogen are necessary
to cause the glands to revert to the prepuberal
rudimentary state. For purposes of comparative
analysis, the replacement dose of ethynyl estra-
diol, which is a rough estimate of the amount
secreted endogenously, is usually less than 0.05
milligram per day (44, 45). Five milligrams of
ethynyl estradiol invariably produced almost
complete obliteration of the glands. Histologi-
cally, 2.5 milligrams daily (approximately fifty
times the physiologic amount) was close to the
threshold while 1.0 milligram daily had no effect.
With the more sensitive gravimetric assay, 0.25
milligram of ethynyl estradiol appears to ap-
proach the threshold. Even this dose is at least
five times the physiologic amount.
It is a fair estimate that ethynyl estradiol is
twenty times more potent than diethylstilbestrol
and thirty times more active than conjugated
estrogenic substances (44, 45); hence, 50 milli-
grams of diethylstilbestrol, approximately equiv-
alent to 2.5 milligrams of ethynyl estradiol,
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Fio. 7. Suppression of sebum output by 1.0 milli-
gram of ethynyl estradiol administered daily to
an adult male and female. Similar changes oc-
curred in two other males and one other female.
could be expected to suppress the glands mod-
erately by histologic criteria. The 20 milligram
dose of Premarin®, corresponding to less then 1.0
milligram of ethynyl estradiol, was without effect
histologically in agreement with expectations.
Forty milligrams of this substance constituted a
histologic threshold dose. It should be noted
that these agents were not evaluated by the
more sensitive gravimetric method of assay. At
the doses used these drugs undoubtedly would
have caused some decrease of sebaceous secre-
tion. In any case, the amount required to produce
almost complete histologic involution is so huge
as to represent a pharmacologic, not a physio-
logic, effect.
A further qualification is necessary. All of
these studies were of relatively short duration (less
than two months). What effect small doses of
estrogen administered over much longer periods
of time would have is not known.
With these high doses, it is not surprising that
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Fio. 8. Suppression of sebum output by 0.5
milligram of ethynyl estradiol administered daily
to an adult male. The drop is similar to that oc-
curring with higher doses of ethynyl estradiol.
Experimental
We first determined the threshold dose which
would just cause glandular suppression at the
treated site. Approximately 0.1 to 0.2 gram of 1.0
per cent ethynyl estradiol in Hydrophylic Oint-
ment, 1J.S.P., was applied to the forehead of four
adult males once daily for seven to ten weeks.
Gravimetrically, sebum output definitely de-
creased in three subjects. This decrease was
already evident in two to three weeks. In the
fourth subject, there was no significant sup-
pression of sebum output.
A 0.5 per cent ethynyl estradiol ointment was
applied daily to the forehead of five more adult
males. In only one of these did sebaceous secretion
decrease. It would appear, then, that the minimal
effective topical concentration of cthynyl estra-
diol lies between 0.5 and 1.0 per cent. It should be
noted, however, that all subjects, including those
whose sebum output was unaffected, experienced
the usual galaxy of estrogenic side effects.
To determine whether estrogen acts directly on
the target organ, the sebaccous gland, the experi-
mental design of the topical androgen study was
followed. The estrogen ointment was applied
locally to one cheek, and the changes in the
sebaceous glands of both cheeks were followed
histologically. A control biopsy specimen was
removed beforehand.
Six post-puberal males, between the ages of 15
and 20 served as subjects. Four received 10 per
cent ethynyl estradiol ointment once daily; two
received 10 per cent beta-estradiol ointment once
daily. The biopsies taken at six weeks revealed a
marked and equal decrease in systemic action.
Feminization was evident in all six subjects,
obviously reflecting percutaneous absorption.
Since histologic examination is not suitable to
serial follow-up, the more sensitive gravimetric
technique was used in the remaining studies. The
estrogen ointment was applied to one side of the
forehead and sebum output was determined on
both sides simultaneously at various intervals.
Ten per cent ethynyl estradiol in Hydrophylic
Ointment, U.S.P., was applied to one side of the
forehead of two adult males once daily. Three
more received 5 per cent ethynyl estradiol oint-
ment. These concentrations greatly exceed the
threshold dose. In all of these subjects, there was
an equivalent decrease in sebaccous secretion on
both sides (Figure 9).
A threshold concentration of 1.0 per cent
ethynyl estradiol ointment was applied to one side
of the forehead of three adult males daily. In two
subjects, sebum production decreased on the
treated side. However, an equally great sup-
pression of sebum output occurred on the un-
treated control side (Figure 10).
Comment
With neither the high (5 to 10 per cent) nor
the threshold (1 per cent) concentration of
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the characteristic systemic effects of estrogen
were displayed in every subject. In the male,
these consisted of softening of the testicles, loss
of libido, breast enlargement and increased
arcolar pigmentation. It is noteworthy that the
larger dosages of 5 to 15 milligrams had feminiz-
ing effects which were no greater than with 1.0
milligram. Every female developed arcolar
pigmentation and amenorrhea followed by with-
drawal bleeding when the drug was stopped.
These effects were reversible since the drug was
generally not given for more than two months.
2) Local Application of Estrogen
As with testosterone we sought to discover
whether cthynyl cstradiol acted directly on the
effcctor organ or via a central mechanism. Here,
too, if one is to prove a direct inhibitory effect at
the target organ, it will be necessary to show a sup-
pressive effect at the application site which is
clearly greater tban that occurring in the control,
untreated site. Obviously adults must be used as
subjects.
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FIG. 9. Decreased sebum output after daily inunction of approximately 0.1gramof 10 per cent ethynyl
estradiol ointment to one side of the forehead of an adult male. Sebum production was assayed simul-
taneously on both treated and untreated sides. Scbaceous secretion decreased sharply but equally on
both sides.
ethynyl estradiol ointment was there any evi-
dence of earlier or greater suppression of scba-
ccous secretion at the treated site. This result
indicates that the effects obtained required
systemic absorption prior to producing the ob-
served results on sebum secretion.
ANTAGONISM BETWEEN ANDROGENS
AND ESTROGENS
It is more of a social than a biological truth
that maleness and femaleness arc opposites.
Endocrinologically, human beings may be con-
sidered ambosexual since both adrogcns and
estrogens arc present in all normal males and
females, although there are marked differences
in the proportions of the various sex steroids.
The gonads arc not the only source of sex hor-
mones. For example, in the male, orchiectomy
only reduces urinary androgens by one-third;
adrcnaleetomy essentially eliminates the remain-
ing source of androgens (46). Ketosteroid excre-
tion in the female is two-thirds of that of a male
(47). Since the adrenals are the predominant
source of androgens in both males and females,
it is not surprising that urinary 17-ketosteroid
excretion is not that much greater in the male.
It is customary in clinical medicine to think of
androgens and estrogens as counteracting or
antagonizing each other. For instance, high
dosages of testosterone are masculinizing and
suppress menstruation in females (48). Con-
versely, high doses of estrogen feminize the male
and ameliorate prostatic cancer, an androgen
dependent malignancy (49, 50). It should be
realized however that these arc biologically
complex situations. Such antithetic responses
probably involve indirect interactions of several
systems. There is no clear understanding of how
such effects are brought about.
The issue before us now is to define experi-
mentally wherein lies the so-called "antagonism"
between estrogens and androgens. The literature
often implies that circulating estrogens and
androgens are struggling or competing with
each other for a target organ such as the uterus
or the sebaceous gland. If the "antagonism" is at
the target organ, there are several theoretical
ways in which this might occur. For example,
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Fin. 10. Decreased sebum output after daily
inunetion of approximately 0.1 gram of 1.0 per
cent ethynyl estradiol ointment to one side of the
forehead of an adult male. Sebum production was
assayed simultaneously on both treated and un-
treated sides. Sebaceous secretion decreased
sharply but equally on both sides.
estrogens could block androgens in the same way
that atropine pharmacologically inhibits acetyl-
choline at the end-organ; or the struggle might
be compared to the pharmacologically opposing
actions of methyl nicotinate and nor-epinephrine
on the cutaneous capillaries. Nicotinate-induced
vasodilation is quickly transformed into vaso-
constriction by the injection of norepinephrine
(51).
The following experiments test whether
estrogen has a direct "neutralizing" or "blocking"
effect on testosterone at the target organ. First,
however, it will be helpful to summarize the
facts established to this point: 1) testosterone
has a direct local effect on the sebaceous glands;
quite small amounts are effective; 2) estrogens
do not appear to act locally; very large un-
physiological amounts are necessary for sup-
pression.
Experimental
Our reasoning in designing these experiments
was that if estrogens counteract androgens at the
target organ, for every dose of androgen, there
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should be an approximately corresponding dose of
estrogen which would cancel its effect. Higher
amounts of androgen would require proportionate
increases in estrogen.
Three different experiments were done. First,
10 milligrams of methyl testosterone and 2 milli-
grams of ethynyl estradiol were simultaneously
administered orally daily to a prepuberal boy for
nine weeks. There was a prompt marked rise in
sebaceous secretion (Figure 11). If one compares
the rise in sebum output when this same subject
was given androgens alone (Figure 2), it will be
seen that the response was identical. The estrogen
did not prevent the androgen from exerting its
growth stimulating action on the gland.
Next, three normal adult males received con-
comitantly 1.0 milligram of ethynyl estradiol and
5 milligrams of methyl testosterone. There was
no suppression in sebaceous secretion (Figure 12).
This small amount of methyl testosterone, which
is less than the endogenous secretion of androgen
maintained sebaeeous secretion in the face of a
suppressive dose of estrogen.
In the final experiment, sebaceous secretion was
first maximally suppressed by large amounts of
estrogen (1 to 20 milligrams of ethynyl estradiol).
At that point, a small amount of methyl testos-
terone (5 to 10 milligrams) was added so that the
prepared subjects received both agents con-
comitantly daily. The result was clear cut. He-
gardless of the amount of estrogen given, the
androgen promptly increased sebum output in all
five subjects. The most dramatic illustration of
the ability of a small amount of androgen to over-
come the suppressive effect of excessive estrogen
is given in Figure 13. While this man was receiving
the massive dose of 20 milligrams of ethynyl
estradiol daily, sebum production rose signifi-
cantly during two courses of 10 milligrams of
methyl testosterone orally.
Comment
These studies rule out the possibility that
estrogens antagonize androgens at the level of
the target organ. In review, the three separate
findings are: 1) the scbaceous glands of the
prepuberal child will respond to exogenous
androgen even in the presence of excess estrogen;
2) if a small quantity of androgen is given to a
normal adult, even large amounts of estrogen
have no inhibiting effect; and 3) after the glands
have been suppressed by estrogens, the introduc-
tion of small amounts of androgen exogenously
will cause prompt increase in sebum output
despite continuing excessive estrogen.
These findings possibly seem to indicate
that the effect of large, quite unphysiological
dosages of estrogen is to block the supply of
androgen available to the sebaceous gland. When
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FIG. 12. Sebum output in an adult male receiv-
ing 1.0 milligram of ethynyl estradiol and 5 milli-
grams of methyl testosterone orally daily simul-
taneously. Normally, this amount of estrogen
would have suppressed sebum output. However,
the androgen maintained sebum output at a
normal level.
threshold amounts of androgen are available,
the presence of estrogens even in extraordinary
quantities is without effect. This suggests possibly
that there is no physiologic antagonism between
androgens and estrogens in the case of the
sebaceous gland.
In many organ systems, casual analysis sug-
gests an androgen-estrogen antagonism at the
target organ. However, many studies indicate
that hormones with opposing actions on a specific
target organ do not exhibit competitive inhibition
at the target organ site. Moore and Price studied
the effect of the simultaneous administration of
androgens and estrogens on the sex structures of
rats (52, 53). Testosterone causes normal develop-
ment of the seminal vesicles and prostate in the
castrate male rat. When estrogen is administered
simultaneously, the development of these
accessory sex structures is not inhibited. In
spayed female rats, estrogens induce vaginal
cornification. When testosterone is administered
simultaneously, cornification proceeds normally.
One may note that this example is the reverse of
the situation that we have studied; that is to say
androgens do not in this ease block a physio-
logical effect of estrogen. All these studies demon-
strate that, providing the specific regulatory sex
hormone is present, the presence of its "antago-
nist" is immaterial.
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FIG. 11. Sebum output in an eleven year old prepuberal boy receiving 10 milligrams of methyl testos-
terone and 2 milligrams of ethynyl estradiol daily orally simultaneously. The estrogen did not block the
expected rise in sebum output from the androgen. This is the same subject as illustrated in Figure 2.
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FIG. 13. This figure again illnstrates the nature of the "antagonism" between androgens and estro-
gens. First, etbynyl estradiol was given to an adult male until sebaceous secretion was suppressed;
then methyl testosterone was added to the regime while continuing the same dose of estrogen. Sebum
output promptly rose. As long as some exogenous testosterone is available, the inhibitory effect of estro-
gen is cancelled. Note that as little as 10 milligrams of methyl testosterone overrides the effect of 20
milligrams of ethynyl estradiol.
Another tissue in which the opposing effects of
androgens and estrogens can be studied is the
cock's comb. The comb is extremely androgen
sensitive (37). Investigators have found that in
the intact cockerel large amounts of estrogens
can inhibit normal comb development (54, 55).
However, even in the face of excessive estrogen,
comb development proceeds normally if small
amounts of exogenous androgen are supplied
(54, 56). Comb growth also is normal when
chorionic gonadotropin is given simultaneously
with estrogens (54). Furthermore, when estrogens
and androgens are administered simultaneously
to capons, male characteristics (growth of the
comb) and female characteristics (development of
plumage) occur simultaneously (58). Each target
organ responds to its appropriate hormone.
It is only fair to mention that controversy does
exist in respect to estrogen-androgen interactions
on the cock's comb. The cock's comb, unlike the
sebaceous gland, is structurally a complex organ
(59, 60), and experimental results may be inter-
preted in different ways. Some investigators,
using the castrated cock instead of the eoekerel
as in the above studies, find that estrogens,
locally or systemically administered, inhibit the
growth stimulating effect of androgens on the
comb (61, 62). Furthermore, when estrogens are
applied topically to one half of the surgically
divided capon's comb after androgens have been
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applied to both halves, much greater atrophy
occurs on the estrogen treated portion of the
comb (38, 63, 64). This seems to be unassailable
evidence for a direct local effect of estrogen.
Closer scrutiny raises some doubts. One of the two
reports involved the use of only two birds (38).
The other contains a gross inconsistency. The
authors applied varying amounts of estrone to
one half of the divided comb of capons (63, 64).
The combs had been previously stimulated by
the topical application of testosterone to both
halves of the comb. While they noted significant
suppression of comb growth when 100 and 200
gamma of estrone were applied, there was no
depression with 160 gamma. If 100 and 200
gamma are effective, how can 160 gamma be
ineffective?
Assuming as we have, that estrogens exert
their effect systemically, how is this brought
about? There is considerable data supporting the
concept that estrogens inhibit the pituitary
production of gonadotropins; this in turn de-
creases the production of androgens by the
testicle. Payne has demonstrated marked histo-
logic changes in the pituitary glands of fowl
treated with estrogens (65). This is indirect
anatomical evidence. Moore and Price (52, 53)
found that estrogens caused atrophy of the ac-
cessory male sex organs, an effect which was
overcome by administering gonadotropins or
transplanting isogenetic pituitary tissue. In
addition, Boas and Ludwig, in a well controlled
study, found that the administration of chorionic
gonadotropin prevented the estrogen induced
atrophy of the cock's comb (54).
In human beings, too, the administration of
estrogens to males decreases androgen produc-
tion (57, 66—68). This probably reflects decreased
pituitary output of gonadotropins (69), as in the
animal experiments. Indeed, the reduction of the
high gonadotropin levels in the post-menopausal
female by exogenous estrogens is great enough to
have been used as an assay for estrogens (70).
If the gonads were the chief source of andro-
gens, the explanations given to this point would
be sufficient. However, even in the male, it is the
adrenal which produces the major amount of
androgen. It is necessary to postulate that estro-
gens, in some way, suppress the synthesis of
androgen by the adrenal. This could be a direct
effect, or an indirect one operating through the
pituitary. Unfortunately, experimental medicine
provides no clear cut answer one way or the
other. There is, however, recent evidence that
estrogens cause a further depression of androgen
secretion in castrated human males (68, 71).
SUMMARY AND CONCLUSIONS
The quantitative effect of estrogens and
androgens upon human sebaceous glands has
been investigated using histologic and gravi-
metric methods.
Androgens, even in less than physiologic
doses, cause great enlargement of the sebaceous
glands of the prepuberal male and female in two
to three weeks.
Androgens, even in high doses, cause no further
enlargement of adult male's sebaceous glands. By
contrast, the glands of some adult females in-
crease moderately as do the partially involuted
glands of aged females.
Topical application of testosterone propionate
has a greater local growth stimulating effect on
the prepuberal gland at the treated site as com-
pared to the untreated side. Testosterone acts
directly on the sebaceous glands.
Estrogens suppress sebaceous secretion only
with unusually high, pharmacologic rather than
physiologic, doses. Maximal histologic suppres-
sion is attained by about 2.5 milligrams of ethynyl
estradiol, approximately fifty times the replace-
ment dose. The threshold suppressive dose
measured by gravimetric technics is about four
times the physiological dose.
A 1.0 per cent ethynyl estradiol ointment,
applied once daily, approaches the topical
threshold level. Lesser concentrations are ineffec-
tive in suppression of sebum production.
The topical application of a 1.0 to 10 per cent
ethynyl estradiol ointment is equally suppressive
on the treated and control sides.
The inhibiting effects of large dosages of
estrogen are not manifested when a small amount
of androgen is given concomitantly. Estrogen
does not antagonize or block the action of andro-
gen peripherally at the target organ. The regula-
tion of the sebaceous gland is solely by means of
androgens. The suppressive effect of extraordi-
narily high doses of estrogen is probably due to
the reduction in the endogenous synthesis of
androgen.
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